General Information of the Compound
| Compound ID |
CP0449153
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
VU 29
4-Nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
890764-36-0
AKOS005266482
AN-16932
B7668
BCP27694
BDBM50187615
CHEMBL411221
DPAP
DTXSID60469437
ES-0027
FT-0704727
GTPL6403
KS-00002WSR
MolPort-020-313-399
N-(1,3-diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide
N-(2,5-diphenylpyrazol-3-yl)-4-nitro-benzamide
N-[2,5-di(phenyl)pyrazol-3-yl]-4-nitrobenzamide
NCGC00370929-02
SCHEMBL1821818
VU 29
VU-29
VU29
ZINC13704338
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H16N4O3
|
||||||||||||||||||
| Molecular Weight |
384.395
|
||||||||||||||||||
| Canonical SMILES |
[O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H16N4O3/c27-22(17-11-13-19(14-12-17)26(28)29)23-21-15-20(16-7-3-1-4-8-16)24-25(21)18-9-5-2-6-10-18/h1-15H,(H,23,27)
Show/Hide
|
||||||||||||||||||
| InChIKey |
KIALCSMRIHRFPL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( VU-29 )
| Drug Name | VU-29 | ||
|---|---|---|---|